MOKSHA8 PHARMACEUTICALS

moksha8-pharmaceuticals-logo

Moksha8 is a leading pharmaceutical company in Latin America. The company is partnered with Roche, Pfizer, BioCryst and Watson in Brazil and Mexico. Moksha8 was founded in 2007 by Simba Gill and TPG Biotechnology. Major investors include TPG Biotechnology and Montreux Equity Partners.

#SimilarOrganizations #People #Financial #Website #More

MOKSHA8 PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Medical Device Pharmaceutical

Founded:
2007-01-01

Address:
Wayne, Pennsylvania, United States

Country:
United States

Website Url:
http://www.moksha8.com

Total Employee:
501+

Status:
Active

Contact:
55 11 3041 9300

Email Addresses:
[email protected]

Total Funding:
224.07 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Domain Not Resolving Apache Euro Microsoft Exchange Online Office 365 Mail


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

david-f-solomon_image

David F. Solomon Board Member @ moksha8 Pharmaceuticals
Board_member

daniel-turner_image

Daniel Turner Board Member @ moksha8 Pharmaceuticals
Board_member

geoffrey-duyk_image

Geoffrey Duyk Board Member @ moksha8 Pharmaceuticals
Board_member

Current Employees Featured

alex-howarth_image

Alex Howarth
Alex Howarth CFO @ moksha8 Pharmaceuticals
CFO

simba-gill_image

Simba Gill
Simba Gill Founder & Chief Executive Officer, President @ moksha8 Pharmaceuticals
Founder & Chief Executive Officer, President

stig-pedersen_image

Stig Pedersen
Stig Pedersen TitleExecutive Chairman @ moksha8 Pharmaceuticals
TitleExecutive Chairman
2014-02-01

not_available_image

Jeannine Medeiros
Jeannine Medeiros Vice President, Human Resources and Investor Relations @ moksha8 Pharmaceuticals
Vice President, Human Resources and Investor Relations

Founder


not_available_image

Simba Gill

simba-gill_image

Simba Gill

Investors List

forest-laboratories_image

Forest Laboratories

Forest Laboratories investment in Funding Round - moksha8 Pharmaceuticals

watson-pharmaceuticals_image

Watson Pharmaceuticals

Watson Pharmaceuticals investment in Series C - moksha8 Pharmaceuticals

montreaux-equity-partners_image

Montreux Equity Partners

Montreux Equity Partners investment in Series B - moksha8 Pharmaceuticals

tpg-biotech_image

TPG Biotech

TPG Biotech investment in Series A - moksha8 Pharmaceuticals

Official Site Inspections

http://www.moksha8.com Semrush global rank: 6.04 M Semrush visits lastest month: 1.35 K

  • Host name: 162-214-164-184.unifiedlayer.com
  • IP address: 162.214.164.184
  • Location: Provo United States
  • Latitude: 40.2342
  • Longitude: -111.6442
  • Metro Code: 770
  • Timezone: America/Denver
  • Postal: 84606

Loading ...

More informations about "moksha8 Pharmaceuticals"

moksha8 Pharmaceuticals - Crunchbase Company …

Moksha8 is a leading pharmaceutical company in Latin America. The company is partnered with Roche, Pfizer, BioCryst and Watson in Brazil and Mexico. Moksha8 was founded in 2007 by Simba Gill and TPG Biotechnology. Major …See details»

M8 Pharmaceuticals - undefined

We partner with pharmaceutical companies to develop and commercialize leading original medicines, ensuring patients in Latin America get the treatment they need.See details»

Acino Completes Acquisition of M8 Pharmaceuticals Significantly ...

Zurich, Switzerland – 4 December 2023: Acino, a Swiss pharmaceutical company headquartered in Zurich, today announced that it has completed the acquisition of M8 Pharmaceuticals (M8), …See details»

M8 Pharmaceuticals, Inc | LinkedIn

Best-in-Class Biopharmaceutical Platform Supported by our teams of local experts, we partner with innovative pharmaceutical companies to help them register, commercialize, and prolong …See details»

Moksha8 - The Org

Moksha8 provides the highest quality medical products and services to patients and clinicians in Emerging MarketsSee details»

moksha8 Pharmaceuticals - Craft

Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders. The Company is focused on the …See details»

moksha8 officially rebrands as M8 Pharmaceuticals

Jun 22, 2021 · October 3rd, 2022 - M8 Pharmaceuticals, formerly moksha8, unveils today a new name, identity, digital presence, and website as part of an ongoing initiative to reaffirm its …See details»

moksha8 Pharmaceuticals - Contacts, Employees, Board Members, …

Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.See details»

moksha8 Pharmaceuticals and Daewoong Pharmaceuticals sign …

Aug 1, 2023 · moksha8 Pharmaceuticals, announced today that it has entered into an exclusive licensing agreement with Daewoong Pharmaceuticals to commercialize botulinum toxin …See details»

Knight Therapeutics invests up to $125m in Latin America-focused …

Canada-based Knight Therapeutics has announced it has closed a strategic financing agreement of up to $125m with US-headquartered Moksha8, which specialises in licensing and marketing …See details»

M8 Pharmaceuticals announces strategic partnership with Janssen …

Sep 29, 2020 · m8 (formerly moksha8) is a specialty pharmaceutical company focused on licensing, marketing and distributing innovative and established therapeutics in the two largest …See details»

Knight Therapeutics invests in Latin America-focused Moksha8

Feb 19, 2019 · Canada-based Knight Therapeutics has announced it has closed a strategic financing agreement of up to $125m with US-headquartered Moksha8, which specialises in …See details»

Forest ties up with Brazil's Moksha8 in up to $125M alliance

Oct 23, 2012 · Brazil's Moksha8 may be saying goodbye to Watson Pharmaceuticals ($WPI) as a minority owner. But it's saying hello to new business from the U.S. generics company--and a …See details»

M8 Pharmaceuticals, Inc | LinkedIn

Best-in-Class Biopharmaceutical Platform Supported by our teams of local experts, we partner with innovative pharmaceutical companies to help them register, commercialize, and prolong …See details»

moksha8 Expands Alliance With Roche to Commercialize $200 …

May 20, 2009 · moksha8,Inc. has expanded its strategic partnership with Rocheto commercialize an additional portfolio of products in Mexico currentlygenerating sales of $140 million USD. …See details»

moksha8 Mexico will commercialize Duaklir and Eklira, the

Aug 1, 2023 · moksha8 Mexico and Astra Zeneca, a leading pharmaceutical company in respiratory therapies, have signed an agreement under which moksha8 Mexico will assume …See details»

Roche in deal with moksha8 for Mexico - The Pharma Letter

May 21, 2009 · Brazil-based moksha8 Inc says that it has expanded its strategic partnership with Swiss drug major Roche to commercialize an additional portfolio of products in Mexico …See details»

Bened Biomedical Grants Exclusive Rights for PS128™ to M8 …

MEXICO CITY, Dec. 8, 2020 /PRNewswire/ -- M8 Pharmaceuticals (formerly moksha8), announced that it has entered into an exclusive licensing agreement with the probiotics …See details»

moksha8 and BioCryst Gain Approval for the Importation and Use …

Jan 12, 2010 · MEXICO CITY and BIRMINGHAM, Ala., Jan. 12 /PRNewswire-FirstCall/ -- moksha8 and BioCryst today announced that moksha8 has been granted approval from …See details»

linkstock.net © 2022. All rights reserved